Learn languages naturally with fresh, real content!

Popular Topics
Explore By Region
FDA approves Medtronic's new Parkinson's device that personalizes brain stimulation in real-time.
The FDA has approved Medtronic's BrainSense Adaptive DBS system, designed to manage Parkinson's symptoms by providing personalized, real-time brain stimulation.
This system adjusts therapy based on individual brain activity, reducing the need for clinic visits by 85% for initial programming compared to traditional methods.
It aims to offer more balanced treatment, adapting to each patient's specific condition and needs.
12 Articles
La FDA aprueba el nuevo dispositivo para Parkinson de Medtronic que personaliza la estimulación cerebral en tiempo real.